We then sought to examine whether CD4+CD25-CD69+ T cells were directly responsible for relapse or if the presence of a tumor induced the increase in this subset of T cells, which led us to the following question: what is the biological role of CD4+CD25-CD69+ T cells during allo-HSCT? The gene discussed is CD4; the disease is neoplasm.